Abstract
AbbVie is boosting its collaboration with the secretive antiaging company Calico, which is backed by Alphabet, Google’s parent company. Both companies will contribute $500 million more to drug discovery efforts that began in 2014. A scientific publication (eLife 2018, DOI: 10.7554/eLife.32733) indicates that the duo is working with a molecule called ISRIB, integrated stress response inhibitor. Other groups previously demonstrated that ISRIB enhances memory and appears to reverse the effects of traumatic brain injury in mice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
